(IN BRIEF) Roche presented new data at the AD/PD 2025 International Conference demonstrating that trontinemab, in its Phase Ib/IIa Brainshuttle™ AD study, achieves rapid and dose-dependent reductions of amyloid plaques in the brain, with significant biomarker improvements observed in fluid … Read the full press release
Posted in Austria, Business, Financial, Healthcare, Industrial, Investment, Management, Marketing, Media, News, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged AD/PD 2025 International Conference, Alzheimer’s disease, amyloid plaques, ARIA-E, biomarkers, Brainshuttle AD study, cognitive impairment, diagnostic solutions, dose-dependent reduction, Elecsys pTau181 plasma test, Levi Garraway, neurogranin, Phase Ib/IIa study, Phase III programme, pTau181, pTau217, Roche, total tau, trontinemab
(IN BRIEF) A groundbreaking AI-powered research platform, POETIC-AI, has been unveiled by scientists from The Institute of Cancer Research, promising to accelerate cancer biomarker discovery. Demonstrated at The Alan Turing Institute’s fifth AI UK conference, the platform integrates diverse clinical … Read the full press release
Posted in Artificial Intelligence (AI), Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged artificial intelligence, biomarkers, cancer research, Cancer Research UK, clinical trial data, Collaborative Research, CT, digital pathology, Dr. Ferran Cardo, Dr. Maggie Cheang, hormone therapy, ICR, Integrated Discovery and Diagnostics programme, Ki67, medical imaging, MRI, natural language AI, Palantir Foundry, POETIC trial, POETIC-AI, Professor Manuel Salto-Tellez, Royal Marsden NHS Foundation Trust, The Institute of Cancer Research, Xixuan Zhu
(IN BRIEF) The EU-funded DORIAN GRAY project, with the University of Liverpool as a key scientific partner, is set to explore the link between cardiovascular disease (CVD) and mild cognitive impairment (MCI). Despite one in three CVD patients experiencing MCI, … Read the full press release
Posted in Education, Healthcare, Science, Society, United Kingdom
Tagged AI, biomarkers, cardiovascular disease, clinical trial, cognitive training, CVD, dementia reduction, digital tool, DORIAN GRAY, Dr Riccardo Proietti, EU-funded, heart failure, Horizon Europe, international collaboration, Liverpool Clinical Trials Centre, MCI, medical avatar, mild cognitive impairment, Prevention Strategies, Professor Carrol Gamble, risk model, University of Brescia, University of Liverpool
(IN BRIEF) Researchers at the Institute of Cancer Research in London have identified genetic markers that predict a significant survival benefit from combining ipatasertib with abiraterone in treating metastatic castration-resistant prostate cancer. In the phase III IPATential150 trial, patients whose … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged abiraterone, AKT inhibitor, biomarkers, clinical trial, genetic markers, Institute of Cancer Research London, ipatasertib, IPATential150 trial, metastatic castration-resistant prostate cancer mCRPC, overall survival, personalized medicine, PIK3CA/AKT1/PTEN pathway, Professor Johann de Bono, PTEN gene, Roche, sequencing techniques, synthetic lethality, targeted therapy, UK patients
(IN BRIEF) A groundbreaking miniaturized spectroscopy module has been created through a partnership between trinamiX, LUMILEDS, and VIAVI Solutions. Designed to run on Qualcomm Technologies’ Snapdragon® 8 Gen 3 reference design, the module brings near-infrared (NIR) spectroscopy to smartphones. This … Read the full press release
Posted in Business, Electronics & Machinery, Germany, Healthcare, Technology, Telecom
Tagged 2023 Qualcomm Snapdragon Summit, Adam Scheer, biomarkers, detector, filter manufacturers, health indicators, LED light sources, light shaping optics, light source, LUMILEDS, Near-infrared spectroscopy, NIR spectroscopy modules, Noman Rangwala, optical filters, Qualcomm Technologies, smartphones, Snapdragon Summit 2023, Snapdragon® 8 Gen 3, spectrometers, trinamiX, VIAVI Solutions, Wilfried Hermes
How can physicians help patients suffering from mental health disorders like chronic pain, depression and stroke? (IN BRIEF) An interdisciplinary team of researchers at TUM is developing new methods to investigate the neuronal patterns underlying cognitive mental disorders such as … Read the full press release
Posted in Education, Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged AI, Big Data, biomarkers, brain data, Brain Implants, chronic pain, cognitive disorders, depression, EEG, Electroencephalography, mental disorders, mental health, NEUROTECH, Neurotechnology, Prof. Julijana Gjorgijeva, Prof. Simon Jacob, stroke, TUM
(PRESS RELEASE) PARIS AND MONTPELLIER, 30-Mar-2022 — /EuropaWire/ — ALCEDIAG announces the launch of the EDIT-B Consortium, supported by the European Institute of Innovation and Technology for Health (EIT Health). This newly formed European public-private partnership aims at advancing precision … Read the full press release
Posted in Artificial Intelligence (AI), Denmark, European Union, France, Healthcare, News, Pharma & Biotech, Science, Spain, Technology
Tagged Alcediag, Alcen, Alexandra Prieux, artificial-intelligence, biomarkers, bipolar, bipolar disorder, blood test, Capital Region of Denmark, depression, diagnostics, EDIT-B Consortium, EIT health, Fundació Clinic per la Recerca Biomèdica, Fundació Sant Joan de Déu, GHU Paris Psychiatrie & Neurosciences, Hospital Clínic de Barcelona, IVD, Jean Marc Bourez, Maurizio Ferrari, mental health, neuropsychiatry, Parc Sanitari Sant Joan de Déu, precision medicine, precision psychiatry, ProductLife Group, Prof. Eduard Vieta, psychiatric disorders, Psychiatry, RNA editing, Synlab, World Bipolar Day
(PRESS RELEASE) GHENT, 12-May-2020 — /EuropaWire/ — Fujirebio Europe, part of Japanese in vitro diagnostics (IVD) testing leader Fujirebio, has just announced the product it distributes across Europe the iAMP® COVID-19 Detection kit from its partner Atila Biosystems, Inc. of … Read the full press release
(PRESS RELEASE) STOCKHOLM, 13-Mar-2019 — /EuropaWire/ — Summa Equity’s acquisition of Olink AB has been supported by EQT Credit through its Mid-Market Credit investment strategy. EQT Credit has provided a senior secured financing in support of the deal. Olink Proteomics … Read the full press release
Posted in Business, Financial, Investment, News, Pharma & Biotech, Sweden
Tagged acquisition, Alexandre Hökfelt, alternative funding, biology, biomarkers, EQT Credit, EQT Mid-Market Credit II, EQT Partners, human protein biomarker research, Olink, Paul Johnson, precision proteomics, private equity, protein biomarker discovery, protein biomarkers, Proximity Extension Assay, refinancings, Summa Equity, unitranche financing, Uppsala
27-8-2013 — /EuropaWire/ — The fourth AFNET/EHRA consensus conference was convened to discuss how to identify the underlying main pathophysiologies of AF in individual patients so that more targeted therapies could be developed to close the mortality gap. Amsterdam, The Netherlands – Tuesday 27 … Read the full press release
Posted in Education, Healthcare, Netherlands, Pharma & Biotech, Science, United Kingdom
Tagged acute revascularization procedures, AFNET, artery thrombotic blockage, atrial fibrillation, atrial fibrillation (AF) mortality gap, biomarkers, coronary plaques, ESC Congress 2013, ESC consensus paper, European Heart Rhythm Association, European Society of Cardiology, myocardial infarction, pathophysiology causing the disease, personalised cardiology, Professor Paulus Kirchhof, Stroke risk scores, The Atrial Fibrillation competence NETwork, The German Competence Network on Atrial Fibrillation, thrombotic blockage
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?